Generated by AI
Vyome Holdings, Inc. is a clinical-stage biotechnology and specialty pharmaceutical company focused on developing next-generation therapeutic solutions for immuno-inflammatory diseases, including rare conditions with unmet medical needs. Operating within the healthcare sector under diversified biopharmaceuticals, the company engages in research and development of innovative pharmaceutical products. Vyome Holdings aims to address challenging diseases through advanced therapies, contributing to medical progress in immunology and rare disease treatment.
Website18 Technology Drive
Irvine, CA, 92618
United States
Summary of Apr 10's posts. Generated by AI.
Summary of Feb 3's posts. Generated by AI.
Summary of Apr 19's posts. Generated by AI.
Investors talking about RSLS also mention these. Each card shows that asset’s own numbers for the past 24 hours.
Valuation and earnings.